The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease - PubMed (original) (raw)
. 2018 Apr;32(4):678-687.
doi: 10.1002/ptr.6017. Epub 2018 Jan 24.
Affiliations
- PMID: 29368409
- DOI: 10.1002/ptr.6017
Free article
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease
Ria Fisher et al. Phytother Res. 2018 Apr.
Free article
Abstract
Banisteriopsis caapi (B. caapi) contains harmine, harmaline, and tetrahydroharmine, has monoamine oxidase inhibitory activity, and has reported antiparkinsonian activity in humans when imbibed as a tea; however, its effects are poorly documented. For this reason, motor function was assessed in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets following administration of B. caapi extract (28.4-113.6 mg/kg; po), harmine (0.1 and 0.3 mg/kg; sc), and selegiline (10 mg/kg; sc), alone or with a submaximal dose of L-3,4-dihydroxyphenylalanine (L-DOPA; 4-7 mg/kg). L-DOPA reversed motor disability, increased locomotor activity, and induced moderate dyskinesia. B. caapi did not increase locomotor activity or induce dyskinesia but at 56.8 and 113.6 mg/kg improved motor disability. The L-DOPA response was unaltered by co-administration of B. caapi. Harmine (0.1 and 0.3 mg/kg) produced a mild improvement in motor disability without affecting locomotor activity or dyskinesia but had no effect on the L-DOPA-induced antiparkinsonian response. Selegiline (10 mg/kg) alone improved motor function to the same extent as L-DOPA, but with only mild dyskinesia, and did not alter the response to L-DOPA, although dyskinesia was reduced. The findings suggest that B. caapi alone has a mild antiparkinsonian effect but does not enhance the L-DOPA response or reduce dyskinesia.
Keywords: Banisteriopsis; MPTP; Parkinson's disease; monoamine oxidase; primate.
Copyright © 2018 The Authors Phytotherapy Research Published by John Wiley & Sons Ltd.
Similar articles
- The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets.
Pearce RK, Smith LA, Jackson MJ, Banerji T, Scheel-Krüger J, Jenner P. Pearce RK, et al. Mov Disord. 2002 Sep;17(5):877-86. doi: 10.1002/mds.10238. Mov Disord. 2002. PMID: 12360536 - Antiparkinsonian Effects of a Metabotropic Glutamate Receptor 4 Agonist in MPTP-Treated Marmosets.
Mann E, Jackson M, Lincoln L, Fisher R, Rose S, Duty S. Mann E, et al. J Parkinsons Dis. 2020;10(3):959-967. doi: 10.3233/JPD-191824. J Parkinsons Dis. 2020. PMID: 32250315 - Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets.
Lincoln L, Fisher R, Jackson MJ, Jenner P, Neumeyer J, Sromek AW, Lees AJ, Rose S. Lincoln L, et al. Mov Disord. 2016 Sep;31(9):1381-8. doi: 10.1002/mds.26626. Epub 2016 May 2. Mov Disord. 2016. PMID: 27133947 Review. - The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P, Marsden CD. Jenner P, et al. J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review.
Cited by
- Evaluation of the Cytotoxicity of Ayahuasca Beverages.
Simão AY, Gonçalves J, Gradillas A, García A, Restolho J, Fernández N, Rodilla JM, Barroso M, Duarte AP, Cristóvão AC, Gallardo E. Simão AY, et al. Molecules. 2020 Nov 28;25(23):5594. doi: 10.3390/molecules25235594. Molecules. 2020. PMID: 33260723 Free PMC article. - Bedside to bench: the outlook for psychedelic research.
Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK. Acero VP, et al. Front Pharmacol. 2023 Oct 2;14:1240295. doi: 10.3389/fphar.2023.1240295. eCollection 2023. Front Pharmacol. 2023. PMID: 37869749 Free PMC article. Review. - Ancient medicinal plants of South America.
VanPool C. VanPool C. Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11087-11089. doi: 10.1073/pnas.1906805116. Epub 2019 May 21. Proc Natl Acad Sci U S A. 2019. PMID: 31113878 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical